Expression and methylation status of different transcripts of RASSF5 in esophageal squamous cell carcinoma

Cong WANG,Wei GUO,Dong-fang LI,Yan-li GUO,Su-peng SHEN,Xiang-lei YANG,Zhi-ming DONG
DOI: https://doi.org/10.3781/j.issn.1000-7431.2014.09.009
2014-01-01
Tumori
Abstract:Objective: To investigate the expressions and methylation status of different transcripts of Ras-association domain family 5 (RASSF5) in esophageal squamous cell carcinoma (ESCC). Methods: The expressions of different transcript mRNAs of RASSF5 in 49 ESCC tissues and the corresponding paracancerous normal tissues and the expression of RASSF5A mRNA in esophageal cancer TE1, TE13, T.Tn and Ec109 cells treated or untreated with 5-aza-2’-deoxycitydine (5-aza-dC) were detected by RT-PCR. The methylation status of RASSF5A in 49 ESCC tissues and the corresponding paracancerous normal tissues and the esophageal cancer cells treated or untreated with 5-aza-dC were detected by methylation-specific polymerase chain reaction (MSP) method. The expression of RASSF5A protein in 49 ESCC tissues and the corresponding paracancerous normal tissues was examined by immunohistochemistry method. Results: RASSF5A was the main transcript that expressed in esophageal squamous epithelium. The expression levels of RASSF5A in TE1, TE13, T.Tn and Ec109 cells after treatment with 5-aza-dC were up-regulated (P < 0.05). The methylation level of RASSF5A was decreased and the unmethylation level of RASSF5A was increased in TE1 cell, while the unmethylation status of RASSF5A gene was observed in TE13, T.Tn and Ec109 cells. The expression level of RASSF5A mRNA in ESCC tissues was lower than that in the corresponding paracancerous normal tissues (P < 0.01). The positive expression rate of RASSF5A protein in ESCC tissues (26.5%, 13/49) was significantly lower than that in the corresponding paracancerous normal tissues (75.5%, 37/49) (P < 0.01). The methylation rate of RASSF5A promoter in ESCC tissues (55.1%, 27/49) was significantly higher than that in the corresponding paracancerous normal tissues (28.6%,14/49) (P < 0.05), and the methylation rate was closely correlated with lymph node metastasis and pathological differentiation (P < 0.01). Conclusion: The main transcript of RASSF5 which is expressed in esophageal squamous epithelium may be RASSF5A. The inactivation of RASSF5A caused by aberrant methylation in its promoter region may be closely related to the occurrence, metastasis and progression of ESCC. DOI:10.3781/j.issn.1000-7431.2014.09.009
What problem does this paper attempt to address?